Form 4: Final Tranche of Chelsea Clinton’s IAC RSUs Vests
Rhea-AI Filing Summary
Form 4 snapshot: On 06/23/2025, IAC Inc. (ticker IAC) director Chelsea Clinton acquired 1,257 common shares when the final tranche of her three-year restricted stock unit (RSU) award vested at a cost basis of $0. After the vesting, Clinton’s aggregate holding rose to 80,466 shares, comprising 51,838 directly held shares and 28,628 deferred share units under the Non-Employee Director Deferred Compensation Plan. Table II shows the RSU balance falling to zero, confirming no remaining unvested derivative securities. The filing also notes that all share amounts were adjusted for IAC’s 03/31/2025 spin-off of Angi Inc. as a special dividend. Because the shares were received through routine equity compensation and not an open-market purchase or sale, the transaction is generally viewed as neutral from a market-signal standpoint.
Positive
- None.
Negative
- None.
Insights
TL;DR: Routine RSU vesting adds 1,257 shares to Chelsea Clinton’s stake; no market-moving signal detected.
The filing records a standard equity-compensation event rather than discretionary buying or selling. The zero cost basis and vesting schedule confirm that the shares were earned rather than purchased, so no incremental cash view can be inferred. Post-transaction ownership of 80,466 shares is modest versus IAC’s 88 million basic share count, implying negligible dilution. There is no change in derivative exposure, and the Angi spin-off adjustment is purely mechanical. Overall, the disclosure carries low informational value for valuation or sentiment, hence a neutral rating.
TL;DR: Final RSU tranche vests; director equity alignment maintained, governance impact minimal.
From a governance lens, the vesting completes a typical three-year RSU cycle that aligns director incentives with shareholder value. The absence of sales suggests Clinton retains long exposure, but because the stake increase is tiny relative to float, voting power remains unchanged. No 10b5-1 plan was marked, indicating the shares were not transacted under a preset trading program. The filing satisfies Section 16 reporting requirements and does not present red-flag issues such as aggressive selling or option repricing. Impact on governance assessments and proxy advisory recommendations is therefore neutral.